# AST SpaceMobile, Inc.: financial statements, quarterly

ASTS · Nasdaq · CIK 1780312 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/asts.md) · [Financials](/companies/asts/financials.md) · [Filings](/companies/asts/filings.md) · [Insiders](/companies/asts/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/asts/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.0](/filings/0000950170-24-127101.md) | [0.0 d](/filings/0000950170-25-030909.md) | [0.5](/filings/0000950170-24-060499.md) | [0.9](/filings/0000950170-24-097099.md) | [1.1](/filings/0000950170-24-127101.md) | [11.3 d](/filings/0000950170-25-030909.md) | [0.7](/filings/0001193125-26-216950.md) | [1.2](/filings/0001193125-26-342550.md) | [14.7](/filings/0001193125-25-274391.md) | [54.3 d](/filings/0001780312-26-000006.md) | [14.7](/filings/0001193125-26-216950.md) | [31.5](/filings/0001193125-26-342550.md) |
| Cost of revenue | $m | [0.0](/filings/0000950170-23-063737.md) | [0.0 d](/filings/0000950170-24-039342.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [0.0](/filings/0000950170-23-063737.md) | [0.0 d](/filings/0000950170-24-039342.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [9.4](/filings/0000950170-24-127101.md) | [10.8 d](/filings/0001780312-26-000006.md) | [4.3](/filings/0000950170-25-069403.md) | [4.5](/filings/0000950170-25-106627.md) | [14.7](/filings/0001193125-25-274391.md) | [5.3 d](/filings/0001780312-26-000006.md) | [7.1](/filings/0001193125-26-216950.md) | [6.4](/filings/0001193125-26-342550.md) | [5.5](/filings/0001193125-25-274391.md) | [9.1 d](/filings/0001780312-26-000006.md) | [7.1](/filings/0001193125-26-216950.md) | [7.8](/filings/0001193125-26-342550.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.3](/filings/0000950170-24-127101.md) | [2.1 d](/filings/0001780312-26-000006.md) | [0.3](/filings/0000950170-25-069403.md) | [0.2](/filings/0000950170-25-106627.md) | [0.6](/filings/0001193125-25-274391.md) | [0.2 d](/filings/0001780312-26-000006.md) | [0.2](/filings/0001193125-26-216950.md) | [0.7](/filings/0001193125-26-342550.md) | [0.4](/filings/0001193125-25-274391.md) | [2.6 d](/filings/0001780312-26-000006.md) | [1.2](/filings/0001193125-26-216950.md) | [1.1](/filings/0001193125-26-342550.md) |
| Net income | $m | [(20.9)](/filings/0000950170-24-127101.md) | [(31.9) d](/filings/0001780312-26-000006.md) | [(19.7)](/filings/0000950170-25-069403.md) | [(72.6)](/filings/0000950170-25-106627.md) | [(172)](/filings/0001193125-25-274391.md) | [(35.9) d](/filings/0001780312-26-000006.md) | [(45.7)](/filings/0001193125-26-216950.md) | [(99.4)](/filings/0001193125-26-342550.md) | [(123)](/filings/0001193125-25-274391.md) | [(74.0) d](/filings/0001780312-26-000006.md) | [(191)](/filings/0001193125-26-216950.md) | [(231)](/filings/0001193125-26-342550.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [133](/filings/0000950170-23-063737.md) | [85.6](/filings/0000950170-25-030909.md) | [210](/filings/0000950170-24-060499.md) | [285](/filings/0000950170-24-097099.md) | [516](/filings/0000950170-24-127101.md) | [565](/filings/0001780312-26-000006.md) | [874](/filings/0000950170-25-069403.md) | [924](/filings/0000950170-25-106627.md) | [1,204](/filings/0001193125-25-274391.md) | [2,336](/filings/0001193125-26-342550.md) | [3,030](/filings/0001193125-26-216950.md) | [2,288](/filings/0001193125-26-342550.md) |
| Current assets | $m | [163](/filings/0000950170-23-063737.md) | [107](/filings/0000950170-25-030909.md) | [240](/filings/0000950170-24-060499.md) | [315](/filings/0000950170-24-097099.md) | [546](/filings/0000950170-24-127101.md) | [600](/filings/0001780312-26-000006.md) | [895](/filings/0000950170-25-069403.md) | [973](/filings/0000950170-25-106627.md) | [1,277](/filings/0001193125-25-274391.md) | [2,459](/filings/0001193125-26-342550.md) | [3,153](/filings/0001193125-26-216950.md) | [2,494](/filings/0001193125-26-342550.md) |
| Total assets | $m | [402](/filings/0000950170-23-063737.md) | [361](/filings/0000950170-25-030909.md) | [502](/filings/0000950170-24-060499.md) | [580](/filings/0000950170-24-097099.md) | [822](/filings/0000950170-24-127101.md) | [955](/filings/0001780312-26-000006.md) | [1,370](/filings/0000950170-25-069403.md) | [1,881](/filings/0000950170-25-106627.md) | [2,551](/filings/0001193125-25-274391.md) | [5,014](/filings/0001193125-26-342550.md) | [6,051](/filings/0001193125-26-216950.md) | [5,855](/filings/0001193125-26-342550.md) |
| Current liabilities | $m | [26.9](/filings/0000950170-23-063737.md) | [46.2](/filings/0000950170-25-030909.md) | [31.9](/filings/0000950170-24-060499.md) | [49.4](/filings/0000950170-24-097099.md) | [94.1](/filings/0000950170-24-127101.md) | [75.9](/filings/0001780312-26-000006.md) | [84.2](/filings/0000950170-25-069403.md) | [118](/filings/0000950170-25-106627.md) | [134](/filings/0001193125-25-274391.md) | [150](/filings/0001193125-26-342550.md) | [171](/filings/0001193125-26-216950.md) | [191](/filings/0001193125-26-342550.md) |
| Total liabilities | $m | [115](/filings/0000950170-23-063737.md) | [147](/filings/0000950170-25-030909.md) | [216](/filings/0000950170-24-060499.md) | [338](/filings/0000950170-24-097099.md) | [319](/filings/0000950170-24-127101.md) | [285](/filings/0001780312-26-000006.md) | [603](/filings/0000950170-25-069403.md) | [724](/filings/0000950170-25-106627.md) | [925](/filings/0001193125-25-274391.md) | [2,622](/filings/0001193125-26-342550.md) | [3,390](/filings/0001193125-26-216950.md) | [3,457](/filings/0001193125-26-342550.md) |
| Long-term debt | $m | [58.5](/filings/0000950170-23-063737.md) | [59.3](/filings/0000950170-25-030909.md) | [161](/filings/0000950170-24-060499.md) | [200](/filings/0000950170-24-097099.md) | [156](/filings/0000950170-24-127101.md) | [156](/filings/0001780312-26-000006.md) | [462](/filings/0000950170-25-069403.md) | [483](/filings/0000950170-25-106627.md) | [698](/filings/0001193125-25-274391.md) | [2,208](/filings/0001193125-26-342550.md) | [2,963](/filings/0001193125-26-216950.md) | [2,963](/filings/0001193125-26-342550.md) |
| Current portion of debt | $m | [0.2](/filings/0000950170-23-063737.md) | [0.3](/filings/0000950170-25-030909.md) | [0.3](/filings/0000950170-24-060499.md) | [0.3](/filings/0000950170-24-097099.md) | [44.6](/filings/0000950170-24-127101.md) | [2.9](/filings/0001780312-26-000006.md) | [3.7](/filings/0000950170-25-069403.md) | [7.6](/filings/0000950170-25-106627.md) | [8.9](/filings/0001193125-25-274391.md) | [12.0](/filings/0001193125-26-342550.md) | [8.2](/filings/0001193125-26-216950.md) | [8.5](/filings/0001193125-26-342550.md) |
| Shareholders' equity | $m | [287](/filings/0000950170-24-127101.md) | [214](/filings/0001780312-26-000006.md) | [286](/filings/0000950170-25-106627.md) | [242](/filings/0001193125-25-274391.md) | [503](/filings/0001193125-25-274391.md) | [669](/filings/0001193125-26-342550.md) | [767](/filings/0001193125-26-342550.md) | [1,158](/filings/0001193125-26-342550.md) | [1,626](/filings/0001193125-25-274391.md) | [2,392](/filings/0001193125-26-342550.md) | [2,661](/filings/0001193125-26-342550.md) | [2,398](/filings/0001193125-26-342550.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(36.1) d](/filings/0000950170-24-127101.md) | [(24.9) d](/filings/0001780312-26-000006.md) | [(48.1)](/filings/0000950170-25-069403.md) | [(16.2) d](/filings/0000950170-25-106627.md) | [(33.4) d](/filings/0001193125-25-274391.md) | [(28.4) d](/filings/0001780312-26-000006.md) | [(28.5)](/filings/0001193125-26-216950.md) | [(43.5) d](/filings/0001193125-26-342550.md) | [(64.5) d](/filings/0001193125-25-274391.md) | [65.0 d](/filings/0001780312-26-000006.md) | [(48.1)](/filings/0001193125-26-216950.md) | [(97.2) d](/filings/0001193125-26-342550.md) |
| Capital expenditure | $m | [73.5 d](/filings/0000950170-24-127101.md) | [22.3 d](/filings/0001780312-26-000006.md) | [39.6](/filings/0000950170-25-069403.md) | [22.2 d](/filings/0000950170-25-106627.md) | [30.3 d](/filings/0001193125-25-274391.md) | [82.0 d](/filings/0001780312-26-000006.md) | [120](/filings/0001193125-26-216950.md) | [310 d](/filings/0001193125-26-342550.md) | [238 d](/filings/0001193125-25-274391.md) | [396 d](/filings/0001780312-26-000006.md) | [262](/filings/0001193125-26-216950.md) | [598 d](/filings/0001193125-26-342550.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [51.7](/filings/0000950170-22-017458.md) | [51.8](/filings/0000950170-22-025059.md) | [51.9](/filings/0000950170-22-017458.md) | [53.2](/filings/0000950170-22-025059.md) | [141](/filings/0000950170-25-106627.md) | [156](/filings/0001193125-25-274391.md) | [224](/filings/0001193125-26-216950.md) | [242](/filings/0001193125-26-342550.md) | [273](/filings/0001193125-25-274391.md) | [291](/filings/0001193125-26-216950.md) | [299](/filings/0001193125-26-342550.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.